News

Zymeron Received Award from the NIH to Develop Rapid Point-of-Care Tests

(Durham, NC, August 1st, 2019) – Zymeron Corporation, a research-based biotechnology company, announced that it received a three-year, SBIR Phase II award from the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) to develop rapid point-of-care diagnostic tests to detect serologic status of individuals for cytomegalovirus (CMV) infection.

Zymeron Relocated to the Frontier Campus, Research Triangle Park

(Durham, NC, September 1st, 2018) – Zymeron Corporation, a research-based biotechnology company, announced that it is relocated to the Frontier Campus Building 400, Research Triangle Park, NC. Frontier Building 400 provides renovated dynamic laboratory spaces for start-ups and small size companies with up to 50 employees.